EP2043659 - Bibliographic data
ANTI-CANCER THERAPY COMPRISING AN H2-BLOCKER, AT LEAST ONE ANTIINFLAMMATORY AGENT AND A CYTOTOXIC AGENT
| Last update | 13/06/2025 |
|---|---|
| Legal status | Brevet déchu |
| Origin | Euro-PCT |
| (73) Holder |
TILTAN PHARMA LTD 1-1 Hi-Tech Village Edmond Safra Campus Givat Ram P.O.B. 39026
91390 Jerusalem
Israël
|
|---|---|
| (72) Inventors |
BEN-SASSON, Shmuel A. 9 Beit-Hakerem Street
96343 Jerusalem
Israël
|
| (74) Agent |
Mail recipient BROWN, DAVID LESLIE Haseltine Lake LLP Redcliff Quay 120 Redcliff Street
Bristol BS1 6HU
Royaume-Uni
|
| (21) Request number | EP07766866.3 |
|---|---|
| (22) Request date | 04/07/2007 |
| (11) Publication number | EP2043659 |
|---|---|
| Publication date | 03/04/2013 |
| (54) Title of the invention | ANTI-CANCER THERAPY COMPRISING AN H2-BLOCKER, AT LEAST ONE ANTIINFLAMMATORY AGENT AND A CYTOTOXIC AGENT |
|---|---|
| (51) International classification | A61K 31/675, A61K 45/06, A61K 31/196, A61K 31/415, A61K 31/425, A61K 31/4402, A61P 35/00, A61K 31/203 |
| International classification (before reform) | None |
| Claimed priority |
(31) Number: 819164 P
(31) Number: 880107 P |
|---|---|
| Initial application | None |
| Divisional application | None |
| Expected annuity |
Annuity: 7 -
Amount: 90 € -
Due date 31/07/2013
Surtax: 7 - Amount: 18 € - Due date 03/02/2014 |
|---|---|
| Last annuity | None |
| Publication | BREVETS D'INVENTION DESIGNANT MC DELIVRES PAR l'OEB - bulletin 2013/2, of 30/06/2013 |
|---|---|
| History | Publication de la délivrance du brevet européen - Legal date 03/04/2013 Entrée en période de grâce du brevet d'invention - Legal date 31/07/2013 Déchéance du brevet d'invention après période de grâce - Legal date 31/07/2013 |